ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,455Medicare Part D Prescriptions Filled, Including Refills

Rank: 86 out of 917

$525K Total Retail Price of All Prescriptions

Rank: 105 out of 917

280 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

22% of this provider’s 280 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

28% of this provider’s 280 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 8,605 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
FUROSEMIDE 467 396 1 7
HYDROCODONE-ACETAMINOPHEN 462 443 S3 2 6
SIMVASTATIN 389 338 3 2
LEVOTHYROXINE SODIUM 361 346 4 3
LISINOPRIL 328 278 5 1
OMEPRAZOLE 325 262 6 4
CITALOPRAM HBR 273 237 7 15
METHADONE HCL 235 148 S2 8 59
POTASSIUM CHLORIDE 235 201 8 16
DIGOXIN 185 180 10 41
WARFARIN SODIUM 178 177 11 10
METOPROLOL TARTRATE 174 151 12 11
GLIPIZIDE 173 145 13 40
FENTANYL 167 137 S2 14 58
OXYCODONE HCL 157 58 S2 15 27
MIRTAZAPINE 153 132 16 39
TRAZODONE HCL 146 133 17 22
METFORMIN HCL 136 107 18 8
POLYETHYLENE GLYCOL 3350 132 121 19 66
SERTRALINE HCL 127 115 20 24
HYDROCHLOROTHIAZIDE 125 115 21 9
GABAPENTIN 120 77 22 17
LOVASTATIN 116 101 23 19
DONEPEZIL HCL 114 114 24 32
NAMENDA 113 113 25 43
ATENOLOL 105 81 26 12
FLUOXETINE HCL 104 71 27 38
TAMSULOSIN HCL 102 99 28 25
ALENDRONATE SODIUM 100 95 29 23
PREDNISONE 95 70 30 34
ATORVASTATIN CALCIUM 89 67 31 14
ZOLPIDEM TARTRATE 84 58 32 21
AMLODIPINE BESYLATE 81 66 33 5
NAPROXEN 80 76 34 107
QUETIAPINE FUMARATE 77 68 35 52
CLOPIDOGREL 72 72 36 50
DIOVAN 67 50 37 49
DIVALPROEX SODIUM 65 65 38 75
LANTUS 65 20 38 37
OLANZAPINE 63 63 40 103
SPIRONOLACTONE 62 55 41 55
VENTOLIN HFA 58 24 42 135
PHENYTOIN SODIUM EXTENDED 58 52 42 155
JANTOVEN 57 57 44 178
ADVAIR DISKUS 54 53 45 47
PROPRANOLOL HCL 53 39 46 126
PLAVIX 52 51 47 84
OXYCODONE-ACETAMINOPHEN 52 43 S2 47 46
RISPERIDONE 51 35 49 51
ALLOPURINOL 51 40 49 31
MORPHINE SULFATE ER 50 12 S2 51 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 2, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.